Total Payments
$65,713
2024 Payments
$3,567
Companies
36
Transactions
241
Medicare Patients
421
Medicare Billing
$19,599
Payment Breakdown by Category
Other$51,280 (78.0%)
Travel$7,745 (11.8%)
Food & Beverage$6,177 (9.4%)
Education$361.34 (0.5%)
Consulting$150.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $51,280 | 22 | 78.0% |
| Travel and Lodging | $7,745 | 36 | 11.8% |
| Food and Beverage | $6,177 | 169 | 9.4% |
| Education | $361.34 | 13 | 0.5% |
| Consulting Fee | $150.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $43,654 | 82 | $0 (2019) |
| Astellas Pharma US Inc | $17,710 | 48 | $0 (2024) |
| Duchesnay USA Incorporated | $980.83 | 8 | $0 (2018) |
| ABBVIE INC. | $823.53 | 21 | $0 (2024) |
| Amgen Inc. | $640.15 | 12 | $0 (2024) |
| Novo Nordisk Inc | $290.79 | 5 | $0 (2021) |
| MILLICENT US INC | $160.64 | 9 | $0 (2024) |
| COMSORT, Inc | $150.00 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $146.59 | 3 | $0 (2023) |
| Myovant Sciences Inc. | $124.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,567 | 29 | Astellas Pharma US Inc ($3,256) |
| 2023 | $14,468 | 33 | Astellas Pharma US Inc ($14,036) |
| 2022 | $955.27 | 25 | ABBVIE INC. ($415.30) |
| 2021 | $532.36 | 11 | Myovant Sciences Inc. ($124.99) |
| 2020 | $218.55 | 8 | Novo Nordisk Inc ($146.70) |
| 2019 | $4,012 | 29 | AMAG Pharmaceuticals, Inc. ($3,516) |
| 2018 | $40,948 | 85 | AMAG Pharmaceuticals, Inc. ($40,024) |
| 2017 | $1,011 | 21 | Duchesnay USA Incorporated ($375.48) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 12/11/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 12/03/2024 | MILLICENT US INC | — | Education | In-kind items and services | $26.70 | General |
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 11/10/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: WOMENS HEALTH | ||||||
| 11/07/2024 | MILLICENT US INC | — | Education | In-kind items and services | $26.70 | General |
| 11/07/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/10/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $515.00 | General |
| 09/26/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Biological | ||||||
| 09/09/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Endocrinology | ||||||
| 08/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Bone Health | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Biological | ||||||
| 08/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Biological | ||||||
| 07/31/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Biological | ||||||
| 05/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Biological | ||||||
| 04/29/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diagnostics | ||||||
| 04/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: VACCINE | ||||||
| 04/12/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Diagnostics | ||||||
| 03/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Biological | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Biological | ||||||
| 02/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,575.00 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 98 | 108 | $8,508 | $3,379 |
| 2022 | 5 | 119 | 128 | $14,791 | $4,788 |
| 2021 | 5 | 104 | 109 | $14,278 | $4,778 |
| 2020 | 5 | 100 | 115 | $20,818 | $6,654 |
Total Patients
421
Total Services
460
Medicare Billing
$19,599
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 24 | $5,101 | $1,272 | 24.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 27 | 27 | $1,507 | $1,005 | 66.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 24 | 24 | $1,555 | $989.76 | 63.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 33 | $344.52 | $112.53 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 27 | $5,739 | $1,438 | 25.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 16 | $5,726 | $1,270 | 22.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 24 | 24 | $1,555 | $1,004 | 64.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 25 | 25 | $1,396 | $952.48 | 68.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 36 | 36 | $375.84 | $123.73 | 32.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 21 | 21 | $7,515 | $1,841 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 19 | $4,038 | $1,221 | 30.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 21 | 21 | $1,361 | $887.88 | 65.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 19 | 19 | $1,061 | $727.13 | 68.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 29 | 29 | $302.76 | $100.92 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 24 | $7,538 | $1,911 | 25.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 15 | 16 | $5,726 | $1,451 | 25.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 29 | 29 | $1,619 | $1,138 | 70.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 26 | 26 | $1,685 | $1,102 | 65.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 20 | $4,251 | $1,052 | 24.7% |
About Dr. David Kurss, MD
Dr. David Kurss, MD is a Gynecology healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720029002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kurss, MD has received a total of $65,713 in payments from pharmaceutical and medical device companies, with $3,567 received in 2024. These payments were reported across 241 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($51,280).
As a Medicare-enrolled provider, Kurss has provided services to 421 Medicare beneficiaries, totaling 460 services with total Medicare billing of $19,599. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Williamsville, NY
- Active Since 06/09/2006
- Last Updated 08/12/2019
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1720029002
Products in Payments
- INTRAROSA (Drug) $43,654
- Veozah (Drug) $16,791
- Osphena (Drug) $752.59
- EVENITY (Biological) $379.86
- Diclegis (Drug) $249.86
- Prolia (Biological) $235.88
- QULIPTA (Drug) $233.70
- UBRELVY (Drug) $230.51
- Saxenda (Drug) $165.80
- MYFEMBREE (Drug) $144.26
- MYRBETRIQ (Drug) $127.19
- ORIAHNN (Drug) $124.99
- Wegovy (Drug) $124.99
- Twirla (Drug) $122.31
- LO LOESTRIN FE (Drug) $110.97
- HARMONIC Product Family (Device) $107.63
- Cologuard Collection Kit (Device) $96.01
- Lupron (Drug) $94.89
- DIVIGEL (Drug) $79.63
- Myrbetriq (Drug) $75.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.